Aosai Kang: Application for marketing authorization of Omertutumab accepted
2026-11-04 17:55:03
According to CoinMeta, Aosai Kang announced that its subsidiary, Jiangsu Aosai Kang Biomedical Co., Ltd., recently received a "Notice of Acceptance" from the National Medical Products Administration, indicating that the company's application for the registration and marketing of its innovative drug, Omertutamab, for domestic production has been accepted.
Bullish 0
Bearish 0Share to 
Source：Jin10 Data
This content is for market information only and does not constitute investment advice.
Follow HQYC official accounts to stay updated
Hot Articles
Refresh
Bitcoin November Price: Can It Hit $90,000?
11-02 13:02
Alphabet Loses $500B, Microsoft FCF Turns Positive: Why?
10-30 12:17
How to Buy BNB? 2026 Potential & Key Risks Explained
10-29 12:50
Bitcoin Below $80K: What's Next? Can StanChart Hit $100K?
10-27 12:47
Where is the Coinbase Sign-Up Entrance? 2026 New User Guide
10-26 12:44
